Our syngeneic and carcinogen-induced CRC models demonstrated that Nat10 ablation enhances CD8+ T cell–dependent tumor control, as evidenced by increased cytotoxic CD8+ T cell infiltration, GzmB/IFN-γ production, and tumor regression. This evidence concerns the gene NAT10 and colorectal carcinoma.